OTCMKTS:VTRLY Vitrolife AB (publ) (VTRLY) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free VTRLY Stock Alerts $13.20 -0.10 (-0.75%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range$13.20▼$13.2050-Day Range$13.20▼$13.3052-Week Range$11.45▼$21.49Volume1 shsAverage Volume100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendHeadlinesStock AnalysisAnalyst ForecastsChartDividendHeadlines Get Vitrolife AB (publ) alerts: Email Address Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. About Vitrolife AB (publ) Stock (OTCMKTS:VTRLY)Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.Read More VTRLY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VTRLY Stock News HeadlinesJune 2 at 8:36 AM | americanbankingnews.comVitrolife AB (publ) (OTCMKTS:VTRLY) Stock Price Down 0.7%October 27, 2023 | finance.yahoo.comVitrolife AB (publ) - Interim report Q3, 2023: Profitable growth globally despite headwind in the U.S.October 18, 2023 | wsj.comVitrolife ABOctober 5, 2023 | finance.yahoo.comElection committee for Vitrolife AB (publ)October 4, 2023 | finance.yahoo.comVitrolife Group Annual and Sustainability Report 2022October 4, 2023 | finance.yahoo.comVitrolife: Conference call interim reportOctober 4, 2023 | finance.yahoo.comVitrolife AB: Interim report Q1, 2023: Good start to the yearOctober 4, 2023 | finance.yahoo.comReport from Annual General Meeting of Vitrolife AB (publ)October 4, 2023 | finance.yahoo.comConference call interim report: Vitrolife AB (publ)October 4, 2023 | finance.yahoo.comInterim report Q2, 2023: Strong growth in APAC - Vitrolife AB (publ)October 4, 2023 | finance.yahoo.comVitrolife AB (publ) announces changes in the Board of DirectorsOctober 4, 2023 | finance.yahoo.comMaria Forss, SVP Consumables business area, to leave the Vitrolife GroupOctober 4, 2023 | finance.yahoo.comCEO has purchased shares in Vitrolife ABSee More Headlines Receive VTRLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vitrolife AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 5/17 Dividend4/26/2024Dividend Payable5/17/2024Today6/02/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:VTRLY CUSIPN/A CIKN/A Webwww.vitrolife.com Phone46-3-17-21-80-00FaxN/AEmployees1,132Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMs. Bronwyn Brophy O´Connor (Age 50)CEO & President Comp: $7.44MMr. Patrik Tolf (Age 54)Chief Financial Officer Mr. Claus Bisgaard (Age 47)Senior Vice President of Technologies Guillermo Ferrando (Age 33)Vice President Strategy & Corporate development Olivia Natens (Age 54)Senior Vice President of Sales & Marketing Frank Pettersson (Age 57)Acting Senior Vice President of HR & Sustainability Mr. Rickard Ericsson (Age 53)Senior Vice President of Consumables Ricardo Capella (Age 56)Senior Vice President Genetic Services More ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors VTRLY Stock Analysis - Frequently Asked Questions Should I buy or sell Vitrolife AB (publ) stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vitrolife AB (publ) in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" VTRLY shares. View VTRLY analyst ratings or view top-rated stocks. How have VTRLY shares performed in 2024? Vitrolife AB (publ)'s stock was trading at $13.30 at the beginning of the year. Since then, VTRLY shares have decreased by 0.7% and is now trading at $13.2047. View the best growth stocks for 2024 here. How often does Vitrolife AB (publ) pay dividends? What is the dividend yield for Vitrolife AB (publ)? Vitrolife AB (publ) declared a dividend on Wednesday, March 27th. Shareholders of record on Monday, April 29th will be given a dividend of $0.0953 per share on Friday, May 17th. The ex-dividend date of this dividend is Friday, April 26th. Read our dividend analysis for VTRLY. How do I buy shares of Vitrolife AB (publ)? Shares of VTRLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VTRLY) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners”Weiss RatingsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceLEAKED: Jeff Bezos' $330 Million GambleBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vitrolife AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.